9-134700009-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000093.5(COL5A1):​c.378G>T​(p.Gln126His) variant causes a missense change. The variant allele was found at a frequency of 0.00171 in 1,613,802 control chromosomes in the GnomAD database, including 22 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 18 hom. )

Consequence

COL5A1
NM_000093.5 missense

Scores

3
12
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 4.19
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012970805).
BP6
Variant 9-134700009-G-T is Benign according to our data. Variant chr9-134700009-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 136918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-134700009-G-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00234 (357/152360) while in subpopulation EAS AF= 0.0324 (168/5178). AF 95% confidence interval is 0.0284. There are 4 homozygotes in gnomad4. There are 223 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 357 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.378G>T p.Gln126His missense_variant Exon 3 of 66 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.378G>T p.Gln126His missense_variant Exon 3 of 66 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.378G>T p.Gln126His missense_variant Exon 3 of 65 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.378G>T p.Gln126His missense_variant Exon 3 of 66 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.378G>T p.Gln126His missense_variant Exon 3 of 66 2 ENSP00000360885.4 P20908-2H7BY82
COL5A1ENST00000464187.1 linkn.800G>T non_coding_transcript_exon_variant Exon 4 of 6 2

Frequencies

GnomAD3 genomes
AF:
0.00235
AC:
358
AN:
152242
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.0326
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000764
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.00367
AC:
923
AN:
251178
Hom.:
7
AF XY:
0.00356
AC XY:
483
AN XY:
135852
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00159
Gnomad EAS exome
AF:
0.0320
Gnomad SAS exome
AF:
0.000686
Gnomad FIN exome
AF:
0.00787
Gnomad NFE exome
AF:
0.000969
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00164
AC:
2399
AN:
1461442
Hom.:
18
Cov.:
32
AF XY:
0.00167
AC XY:
1217
AN XY:
726998
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00184
Gnomad4 EAS exome
AF:
0.0342
Gnomad4 SAS exome
AF:
0.000777
Gnomad4 FIN exome
AF:
0.00723
Gnomad4 NFE exome
AF:
0.000383
Gnomad4 OTH exome
AF:
0.00179
GnomAD4 genome
AF:
0.00234
AC:
357
AN:
152360
Hom.:
4
Cov.:
32
AF XY:
0.00299
AC XY:
223
AN XY:
74498
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00231
Gnomad4 EAS
AF:
0.0324
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.0105
Gnomad4 NFE
AF:
0.000764
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00237
Hom.:
12
Bravo
AF:
0.00181
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00369
AC:
448
Asia WGS
AF:
0.0120
AC:
41
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000533

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Oct 14, 2015
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 06, 2014
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:2
Dec 14, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

COL5A1: BS1, BS2 -

Ehlers-Danlos syndrome, classic type, 1 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 15, 2022
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Dec 20, 2016
Ambry Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ehlers-Danlos syndrome type 7A Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ehlers-Danlos syndrome Benign:1
Oct 19, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1;C5543412:Fibromuscular dysplasia, multifocal Benign:1
Nov 11, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Uncertain
-0.050
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.59
D;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.97
D;D
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
-0.17
T
MutationAssessor
Pathogenic
3.6
H;H
PrimateAI
Uncertain
0.62
T
PROVEAN
Uncertain
-3.4
D;.
REVEL
Pathogenic
0.70
Sift
Uncertain
0.0020
D;.
Sift4G
Uncertain
0.0020
D;D
Polyphen
0.99
D;.
Vest4
0.83
MutPred
0.43
Gain of sheet (P = 0.1208);Gain of sheet (P = 0.1208);
MVP
0.82
MPC
0.62
ClinPred
0.10
T
GERP RS
2.9
Varity_R
0.46
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145178917; hg19: chr9-137591855; API